Fritextsökning
Innehållstyper
-
RegFile AB
-
Mercodia AB
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
The Swedish Life Science Office: “We lost in both coordination and manpower”
Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...
-
Optimize Courier SUPPLIERS (DISTRIBUTORS)
-
The future of healthcare in focus: ”Together, things happen”
In march, it’s once again time for Fokus Patient, an event for the industry where the patients’ perspective takes center stage. It’s a great way to spread knowl...
-
Explore our tailored program for Control 2025
Choose an innovation tour, or join our industry-specific guided tours.
-
Investment CEO: “The Nordics are outstanding in creating successful medtech companies”
Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
Non-destructive testing and assembly control
Assess complete assembly.
-
Genmabs antikroppskonjugat får japanskt godkännande
Danska Genmab har fått japanskt godkännande för sin behandling för avancerad eller återkommande livmoderhalscancer.
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
Scientific Solutions
-
Speed meets precision for high-density components
ZEISS METROTOM 800 320 kV.
-
AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence
AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.
-
Han tar över som CMO på Alligator Bioscience
Alligator Biosciences nya CMO kommer att vara en stor tillgång när arbetet att ta huvudkandidaten mitazalimab till fas III fortsätter, uppger bolaget.
-
Lonza
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7.
-
ProPharma
-
SGS Fimko Ltd.
-
QPS Netherlands B.V
-
Fundamental Aspects of Airy Disk Patterns
Knowledge Article from ZEISS.
-
Trump in new push to lower drug prices
U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...
-
Astra Zeneca faces potential multimillion-dollar fines in China
Astra Zeneca could be forced to pay up up to $8 million in fines for allegedly unpaid import duties in China, as the company seeks to rebuild trust following ea...